TMBquant:一个可解释的人工智能驱动的呼叫者,在异质样本中推进瘤突变负担量化.
Shenjie Wang1,2,3, Xiaonan Wang2,4, Xiaoyan Zhu2,3
1Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157, Xiwu Road, Xincheng District, Xi'an 710004, China.
Briefings in bioinformatics
|September 8, 2025
概括
TMBquant是一种基于人工智能的工具,准确估计瘤突变负担 (TMB),以改善免疫治疗患者的分层. 它在不同类型的癌症中优于现有方法,为精密瘤学提供了可靠的解决方案.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 人工智能在瘤学中的应用
背景情况:
- 准确的瘤突变负担 (TMB) 量化对于预测免疫治疗反应至关重要.
- 现有的变异调用者表现出变异性,影响TMB估计的准确性和临床实用性.
- 挑战包括测序平台的差异,瘤异质性和多样化的变异调用管道.
研究的目的:
- 开发和验证TMBquant,一个可解释的AI驱动的变体调用器,用于优化TMB估计.
- 为了提高TMB量化准确性,稳定性和可复制性,跨多种数据集.
- 为了证明TMBquant在免疫治疗患者分层中的卓越性能.
主要方法:
- TMBquant使用H2O AutoML进行动态特征选择和组合学习.
- 它整合了变体特征,并将分类错误降到最低,以便进行可靠的TMB估计.
- 基准测试涉及对706个全外因组测序瘤控制对进行与9个已确定的变异调用者的比较.
主要成果:
- 在NSCLC和NPC队列的生存分析中,TMBquant始终实现了最高的危险比率.
- 与所有基准方法相比,它显示出优越的患者分层.
- 在高TMB (NSCLC) 和低TMB (NPC) 设置中观察到强的性能,这表明可概括性.
结论:
- TMBquant是一种可靠,可复制和临床可操作的精密瘤学工具.
- 它的人工智能驱动的方法优化TMB估计,增强免疫疗法分层.
- 该开源软件在癌症基因组学分析方面取得了重大进展.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K


